Publication | Open Access
Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease
163
Citations
33
References
2019
Year
Our results encourage an independent validation cohort study to confirm the indication that the plasma Aβ<sub>1-40</sub>/Aβ<sub>1-42</sub> ratio, assessed via Simoa, may improve future standard of care and clinical trial design.
| Year | Citations | |
|---|---|---|
Page 1
Page 1